Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Infliximab may cause hair loss in Crohn's disease patients.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Baricitinib is the most effective treatment for alopecia areata.

Baricitinib effectively regrew hair in a woman with alopecia universalis after other treatments failed.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Dupilumab improves eczema in Netherton Syndrome but not ichthyosis linearis circumflexa.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Apremilast shows promise for several skin conditions but needs more research.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

Pulsed electric field treatment may help shrink untreated liver tumors.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.